FI960226A - 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one - Google Patents

9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one Download PDF

Info

Publication number
FI960226A
FI960226A FI960226A FI960226A FI960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A
Authority
FI
Finland
Prior art keywords
alkoxyphenyl
purin
substituted
Prior art date
Application number
FI960226A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI960226A0 (en
Inventor
Ulrich Niewoehner
Erwin Bischoff
Helmuth Schuetz
Elisabeth Perzborn
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI960226A0 publication Critical patent/FI960226A0/en
Publication of FI960226A publication Critical patent/FI960226A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI960226A 1995-01-19 1996-01-17 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one FI960226A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (en) 1995-01-19 1995-01-19 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one

Publications (2)

Publication Number Publication Date
FI960226A0 FI960226A0 (en) 1996-01-17
FI960226A true FI960226A (en) 1996-07-20

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960226A FI960226A (en) 1995-01-19 1996-01-17 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one

Country Status (30)

Country Link
US (1) US5866571A (en)
EP (1) EP0722943A1 (en)
JP (1) JPH08231546A (en)
KR (1) KR960029335A (en)
CN (1) CN1138583A (en)
AR (1) AR002704A1 (en)
AU (1) AU4097796A (en)
BG (1) BG61729B1 (en)
BR (1) BR9600149A (en)
CA (1) CA2167349A1 (en)
CO (1) CO4700524A1 (en)
CZ (1) CZ16896A3 (en)
DE (1) DE19501480A1 (en)
EE (1) EE9600020A (en)
FI (1) FI960226A (en)
HR (1) HRP960009A2 (en)
HU (1) HUP9600107A3 (en)
IL (1) IL116771A (en)
MA (1) MA23779A1 (en)
NO (1) NO960221L (en)
NZ (1) NZ280829A (en)
PE (1) PE10597A1 (en)
PL (1) PL312353A1 (en)
SG (1) SG47379A1 (en)
SK (1) SK7696A3 (en)
SV (1) SV1996000004A (en)
TN (1) TNSN96005A1 (en)
TR (1) TR199600701A2 (en)
YU (1) YU2896A (en)
ZA (1) ZA96399B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (en) * 1998-08-24 2000-03-02 Bayer Ag 9-dialkylaminopurinone derivatives
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
NZ524572A (en) * 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
JP4179784B2 (en) * 2001-02-15 2008-11-12 田辺三菱製薬株式会社 Orally disintegrating tablets
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
DE60222931T2 (en) * 2001-12-13 2008-07-10 Asubio Pharma Co., Ltd. PYRAZOLOPYRIMIDINONE DERIVATIVES WITH PDE7-HEMMENDER EFFECT
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
WO2003087037A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Substituted aryl amides
EP3157520B1 (en) 2014-06-23 2019-09-04 Celgene Corporation Apremilast for the treatment of a liver disease or a liver function abnormality

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (en) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents

Also Published As

Publication number Publication date
EE9600020A (en) 1996-08-15
FI960226A0 (en) 1996-01-17
CN1138583A (en) 1996-12-25
NO960221D0 (en) 1996-01-18
PL312353A1 (en) 1996-07-22
NO960221L (en) 1996-07-22
JPH08231546A (en) 1996-09-10
EP0722943A1 (en) 1996-07-24
CA2167349A1 (en) 1996-07-20
HRP960009A2 (en) 1997-12-31
BG100291A (en) 1996-07-31
TR199600701A2 (en) 1996-08-21
DE19501480A1 (en) 1996-07-25
IL116771A (en) 1999-06-20
HU9600107D0 (en) 1996-03-28
YU2896A (en) 1999-03-04
US5866571A (en) 1999-02-02
SV1996000004A (en) 1997-02-19
TNSN96005A1 (en) 2005-03-15
CO4700524A1 (en) 1998-12-29
IL116771A0 (en) 1996-05-14
NZ280829A (en) 1998-04-27
AU4097796A (en) 1996-07-25
HUP9600107A3 (en) 1999-06-28
BR9600149A (en) 1998-01-06
KR960029335A (en) 1996-08-17
SG47379A1 (en) 1998-04-17
ZA96399B (en) 1996-08-14
MA23779A1 (en) 1996-10-01
BG61729B1 (en) 1998-04-30
HUP9600107A2 (en) 1997-05-28
SK7696A3 (en) 1996-08-07
CZ16896A3 (en) 1996-08-14
PE10597A1 (en) 1997-06-13
AR002704A1 (en) 1998-04-29

Similar Documents

Publication Publication Date Title
DE59510981D1 (en) chuck
DE69635106D1 (en) guanine
DE69612854T2 (en) CHUCK
DE69620884T2 (en) KODEMULTIPLEXVIELFACHZUGRIFFSNACHRICHTENÜBERTRAGUNGSSYSTEM
FI960226A (en) 9-substituted 2- (2-n-alkoxyphenyl) -purin-6-one
ATA135896A (en) SKIBOB
DE69618742T2 (en) circuitry
DE69616610D1 (en) Mandrel
ATE198470T1 (en) ALKENYL-BENZOYLGUANIDINE
DE69619622T2 (en) circuitry
ATE240972T1 (en) CYCLOPEPTOLIDES
ATA119896A (en) Scheibenmähwerk
DE59600405D1 (en) HELP
FI1943U1 (en) Bomsystem till skogmaskin
FI2187U1 (en) Hoerndetalj till plaottlaoda
FI2196U1 (en) Snoestyrningsblad till snoeslunga
FI2002U1 (en) Haollare till spoestaell
FI1863U1 (en) Vaeggkonstruktion till timmerhus
FI950084A0 (en) Instaellbart ryggstoed till patientstol
FI950280A0 (en) Smaeltsaekring till en brandsaekerhetsanordning
FI954177A0 (en) Tillaeggsanordning till lyfttruck
FI951168A0 (en) Kraftoeverfoeringsanordning till rotationskolvmotor
FI950851A0 (en) Mekanism till kraftoeverfoeringsanordning
FI950830A0 (en) Skaer till valskross
FI950473A0 (en) Vaeggkonstruktion till timmerhus